Fifth Circuit· 5/15/2013

Wellogix, Inc. v. Accenture, L.L.P.

Citations

716 F.3d 867
91 Fed. R. Serv. 499
106 U.S.P.Q. 2d (BNA) 1796
2013 WL 2096356
2013 U.S. App. LEXIS 9758

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

affirming the admission of a computer scientist as an expert who initially lacked experience in the software at issue in the case
“[The] expert . . . [testified] that the company was worth $27.8 million in 2005.”
“Although Accenture maintains that it was Wellogix’s burden to show that the patents did not cover the same subject matter, Accenture does not cite, nor could we find, case law imposing such a burden.”
“any exploitation of [a] trade secret that is likely to result in injury to the trade secret owner or enrichment to the defendant is a ‘use,’” including “an act that ‘lower[s] the market value’ of a trade secret”

Source: CourtListener parenthetical corpus (CC0).

Judges: Demoss, Southwick, Higginson

Read full opinion on CourtListener

Cited by

57 cases in this archive cite this case; the 20 most cited are listed.

Cites

72 cases in this archive are cited by this case; the 20 most cited are listed.

Other cases named Wellogix, Inc. v. Accenture, L.L.P.

2 other CourtListener records share this case name.

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.